Our world-renowned experts and caregivers offer comprehensive and compassionate treatment to patients with end-stage liver, kidney, and pancreas organ failure who might benefit from transplantation. We offer options and hope for high-risk patients who may have been turned down for transplant elsewhere, in addition full support services.
Our experts include physicians specializing in anesthesiology, internal medicine, pediatrics, surgery, transplant immunology, kidney diseases, liver diseases, diabetes mellitus, and transplant surgery. Our caring, highly skilled nurses, physician assistants, financial coordinators, nutritionists, pharmacists, and social workers further support our patients’ needs.
We offer comprehensive evaluation and diagnosis for patients with end-stage liver and kidney diseases; tissue typing and immune evaluation services; leading-edge treatment options for immunosuppression; and follow-up and psychosocial support.
Yale New Haven Transplantation Center was the first Connecticut institution to provide liver, kidney, and pancreas transplantation services
The first kidney paired exchange in Connecticut
The first split-liver transplant in the state
The largest kidney transplantation program in New England; the largest living donor kidney transplantation program in New England
A nationally recognized pediatric liver transplant program in both patient outcomes and number of living donor transplants performed
Many inherited metabolic liver diseases such as Wilson's disease, Gaucher's disease, lipidosis, alpha-1 antitrypsin deficiency, hemochromatosis, tyrosinemia, and glycogen storage diseases are cured by successful liver transplantation. We specialize in genetic testing for liver diseases and treatments that provide comprehensive care for affected patients. Even though we treat some of the most seriously ill patients, our program's survival rates are consistently higher than the national average.
We offer many options for advanced liver disease, including living donor and deceased donor transplantation, liver transplantation in HIV-infected individuals, and pre- and post-transplant antiviral therapy to prevent or treat recurrent hepatitis C.
Through our acute liver failure program, we can transfer patients to Yale New Haven Hospital in a timely manner for transplant evaluation and medical management. In collaboration with the hospital’s Medical Intensive Care Unit, we offer innovative techniques such as hypothermia therapy for the treatment of acute liver failure.
Pancreatic transplants are less common than kidney or liver transplants, and are usually performed in patients with type 1 diabetes. Our physicians perform isolated pancreas transplantation, simultaneous kidney/pancreas transplantation, and pancreas transplantation following kidney transplantation.